Lifevibe VAT Chair Prime- The World’s First Consumer-Grade Vibroacoustic Therapy Chair Officially Launched
Montclair, CA, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Lifevibe® has launched the…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear…
HKUST Commences Preparations for New Medical School
Inaugural Cohort in 2028, Cultivating Clinically Excellent and Technology-Savvy Doctors of the Future…
Robert Lewandowski Named Global Brand Ambassador for KSM-66 Ashwagandha
FC Barcelona Striker Partners with Most Clinically Researched Ashwagandha Brand, KSM-66 LOS…
Clinically Proven Human Milk Probiotic LC40 supports Infant Health and Breastfeeding Mothers
SINGAPORE, Sept. 15, 2025 /PRNewswire/ --Â Supported by six clinical studies and two…
Angelalign Technology Denies Patent Infringement and Vows Vigorous Defense
SAN CLEMENTE, Calif., Aug. 20, 2025 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") categorically denies…
Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025
- Presentations highlight clinically meaningful reductions in BMI in patients with acquired…
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Data presented simultaneously at the American Diabetes Association’s® 85th Scientific Sessions, showed…